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Abstract 
The purpose of this study was to address the well-established problem of poor medication 
adherence within mental health settings by designing a psychoeducational program to educate 
clients about the medications they are prescribed. The program was intended to be implemented 
within a community mental health setting and was scheduled to be facilitated by pharmacists 
affiliated with this agency. Assessments were also developed to evaluate the effectiveness of the 
new program. However, after an absence of participant involvement, a focus group was 
established to generate solutions to the lack of client attendance problem. Suggestions were 
generated for future program designs that might mitigate the observed problems.   
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Development of a Psychoeducational Program Designed to Improve Medication Adherence 
in a Community Mental Health Setting 
 Psychopharmacological treatments for mental disorders began in the 1950s and have 
flourished over time with the development of new generations of drug treatments. Today, many 
individuals are prescribed psychotropic medications to help alleviate some of the negative 
symptoms that accompany certain mental health conditions (Howland, 2007). Most individuals 
will see symptom improvement from their medications, but poor adherence to prescribed 
medication regimens is a growing concern in both the mental health field and the larger medical 
community. “Adherence to (or compliance with) a medication regimen is generally defined as 
the extent to which patients take medications as prescribed by their health care providers” 
(Osterberg & Blaschke, 2005, p. 487). Adherence rates are generally calculated as the percentage 
of a prescribed dose that the patient or client actually consumes relative to the dose prescribed. 
Unfortunately, the average adherence rates in most clinical trials falls between 43% and 78% 
within medical settings, whereas the rates of adherence that are considered to be acceptable in 
order to achieve the desired treatment effect range from 80 to 95% (Osterberg & Blaschke, 
2005). In addition, patients with psychiatric conditions typically have adherence rates that are 
significantly lower than the general medical population. Individuals with depression have 
average adherence rates of 65%, and patients with psychotic disorders have average adherence 
rates of only 58% (Osterberg & Blaschke, 2005). It is estimated that non-adherence among 
individuals with medical or mental health conditions can cost society a total of $396 to $792 
million in additional medical costs (LaFleur & Oderda, 2004).  
 Several researchers have begun to question the factors related to the poor rates of 
adherence that are observed within the medical and mental health communities. When surveyed, 
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30% of patients attributed poor adherence to forgetfulness, 16% reported that they had other 
priorities (which may be related to financial concerns), 11% cited a decision to omit doses on 
their own for unstated reasons, 9% cited a lack of information as the reason behind their decision 
to discontinue use, and 7% cited emotional factors (Osterberg & Blaschke, 2005). Also, certain 
symptoms of psychiatric conditions such as hopelessness, poor insight, delusional thinking, or 
cognitive difficulties may also play a part in poor adherence rates among individuals with 
psychiatric conditions. Some individuals may choose to suspend their medications because they 
have begun to experience symptom remission and thus they may mistakenly believe that they no 
longer need their medication. Finally, an intolerance or poor understanding of side effects may 
also play a role in an individual’s decision to terminate psychopharmacological treatment 
(Howland, 2007). Due to these factors, LaFleur and Oderda (2004) suggested that providers first 
question medication non-adherence in patients before they determine that a certain 
pharmacological treatment is ineffective.  
 In a study by Sawada et al. (2009), the researchers analyzed the medical charts of patients 
who were diagnosed with major depressive disorder to better understand adherence rates of 
patients who had a chronic mental health condition. They found that only 41% of patients were 
able to remain compliant after six months of psychopharmacological treatment, a finding that has 
been duplicated across the literature (Osterberg & Blaschke, 2005). Additionally, they found that 
most patients discontinued their antidepressant medications without consulting their prescribers, 
and a similar result was also found for those who were prescribed anxiolytics. Clinicians and 
prescribers therefore need to understand that medication adherence is a potential concern for 
patients with mental and emotional conditions, and thus strategies need to be implemented that 
will mitigate this problem within the mental health field.  
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Literature Review 
Several researchers have suggested intervention strategies that could potentially improve 
adherence rates amongst those undergoing pharmacological treatments. Osterberg and Blaschke 
(2005) suggested four areas for intervention: patient education, improved dosing schedules, 
increased access to medication providers, and improved communication between patient and 
prescriber. Psychoeducational programs designed to educate patients about their medications 
have been implemented across a variety of settings and for different health concerns, and this 
method may be one of the most practical and cost-effective options available. It is therefore 
imperative to determine if psychoeducational interventions can be used to improve medication 
adherence rates amongst patients in the mental health community as this can ultimately be a 
simple and effective solution for the growing adherence problem.  
 George, Elliot, and Stewart (2008) reviewed studies that implemented medication 
adherence interventions in medically-based community samples of elderly patients who were 
prescribed at least three different concurrent medications. The psychoeducational components in 
several of the studies reviewed involved providing patients and their families with a written 
document that detailed information regarding a patient’s specific medications. Other strategies 
such as memory aids and visual tools were also employed. Although they found 
psychoeducational interventions to be helpful in some circumstances, the overall results were 
inconsistent across all of the settings. The authors suggested that future researchers continue to 
investigate psychoeducational interventions so that more concrete conclusions can be made.  
 MacKay and Corkum (2006) investigated an ADHD Demystification Workshop which 
was designed to provide children in second through seventh grade with information about 
ADHD symptomatology and corresponding treatments. The goal of the study was to evaluate the 
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effectiveness of such a program at increasing children’s general knowledge about their condition. 
The workshop consisted of two hours of evidenced-based information about ADHD and 
associated treatments. The researchers hypothesized that children who participated in the 
workshop would show a better understanding of their disorder on measures of knowledge and 
retention. The authors utilized the ADHD Knowledge and Opinion Scale (AKOS; Rostain, 
Power, & Atkins, 1993), and the children were asked to complete it both before and after the 
workshop. The results indicated that the children had an increased knowledge about ADHD 
following the workshop and that they had a more favorable opinion about standard treatments 
(MacKay and Corkum, 2006). This finding indicated that psychoeducational programs are 
capable of improving an individual’s knowledge about his or her condition, and this may lead to 
an increase in other favorable outcomes as well.  
 Lopez, Toprac, Crismon, Boemer, and Baumgartner (2005) conducted a preliminary 
investigation regarding the effects of a psychoeducational program for ADHD on children and 
families involved in the Children’s Medication Algorithm Project (CMAP). The researchers 
gathered several informative tools from both the mental health literature and government 
agencies, and the materials were provided to the patients after the decision was made by the 
families to begin pharmacological treatments. The children and parents were provided with 
information regarding the advantages and disadvantages of taking specific medications, and they 
were also provided with information about proper dosing and what to expect while undergoing 
this form of treatment. In addition, the parents were provided with detailed handouts that 
discussed the importance of communicating with one’s prescriber as well as specific questions 
they might ask. Additional handouts were provided that delineated possible expectations for a 
particular medication including: benefits, potential side effects, the expected time frame until one 
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would see any medication effects, a general description of the medication mechanisms, and what 
to do if the medication did not work. Over 90% of families received this information in several 
formats including handouts and audio-video format. On a measure of patient satisfaction, the 
results of this study indicated that parents were content with the amount of information that was 
provided and that they found it helpful when attempting to better understand their child’s 
diagnosis. A further investigation is underway by the authors to analyze the treatment adherence 
effects of such a program.  
 In another study, Balfour et al. (2006) investigated the use of a psychoeducational 
intervention (STAART) within a sample of patients with HIV. The goal of the program was to 
improve patients’ readiness for treatment as well as treatment adherence before initiating an 
intense anti-viral treatment regime. The information that was provided consisted of treatment 
adherence strategies as well as coping strategies for stress and depressive symptoms. Patients 
were provided with questionnaires regarding their readiness to begin treatment before and after 
the implementation of the program. The authors stated that medication knowledge is one of the 
most salient predictors of treatment adherence amongst HIV patients. The psychoeducational 
intervention consisted of four weekly meetings, and results indicated that the intervention 
increased treatment readiness compared to other standard treatments. Additionally, many of the 
individuals in the study had reduced depressive symptoms following the completion of the 
psychoeducational program.  
 Sajatovic, Chen, Dines, and Shirley (2007) conducted a review of the literature on 
psychoeducational interventions designed to improve medication adherence in individuals with 
bipolar disorder. The authors stated that bipolar disorder remission rates can often be directly 
linked to poor medication compliance, and their goal was to discover if simple 
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psychoeducational programs could improve this problem. They found that the largest gains in 
medication adherence were the result of specific psychoeducational interventions. They also 
discovered that, in most studies, individuals with bipolar disorder were relatively uninformed 
about their disorder when they began psychopharmacological treatments and thus the authors 
suggested that psychoeducational programs be utilized to allow individuals to have a more active 
role in managing their symptoms.  
 In a study by Cakir, Bensusan, Akca, and Yazici (2009), the authors also investigated the 
overall effects of a psychoeducational program for patients with Bipolar disorder. They found 
that psychoeducational programs designed to improve treatment compliance also improved 
patients’ overall quality of life by instilling healthy habits to follow and by providing patients 
with information about how to recognize the prodromal signs of a manic episode. The 
psychoeducational program utilized lasted a total of six weeks, and participants were classified 
as either good or poor attenders based on whether or not they made at least 75% of the weekly 
meetings. The authors found that those who were more likely to be consistent attenders were 
those with a more chronic outlook: those who had a family history of bipolar disorder and those 
with a history of suicide attempts. The authors found that their program improved overall 
treatment compliance including medication adherence, and these results suggest that 
psychoeducational interventions can be used to help individuals who may have the most severe 
forms of certain mental illnesses. 
 Additionally, in the realm of severe mental illness, Cramer and Rosenheck (1999) 
developed the Medication Usage Skills for Effectiveness (MUSE) program which was designed 
to teach severely mentally ill patients to become more compliant with their medication regimens. 
The initial program was implemented within an inpatient VA day program, and it was used to 
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inform patients about different cues they could implement to help them to remember to take their 
medications. The authors also utilized monthly follow-up visits to implement visual aids such as 
calendars to further assist the patients. They found that those who were involved in the MUSE 
program had significantly better medication adherence rates (76%) than those in the control 
group (57%). The results of this study suggest that a simple, focused psychoeducational 
intervention can improve medication adherence amongst individuals with severe mental 
illnesses.  
Purpose of This Study 
As many researchers suggested, poor medication adherence amongst individuals with 
psychiatric conditions is a growing concern within the mental health field (Osterberg & 
Blaschke, 2005). A simple and cost-effective method for improving adherence rates involves 
implementing a psychoeducational program designed to facilitate communication with 
prescribers and to provide information on the effects and potential side effects of one’s 
prescribed medications. This method has been employed in several medical and mental health 
settings, and researchers have found that psychoeducational programs have improved knowledge 
about prescribed medications and have, in some cases, effectively improved adherence rates as 
well. With specific regards to mental health settings, several authors (Cramer & Rosenheck, 
1999; Sajatovic, Chen, Dines, & Shirley, 2007) have found that psychoeducational programs 
helped to improve overall adherence rates when assessed via self-report measures. Although 
these findings are promising, there has been a paucity of research regarding the effectiveness of 
psychoeducational programs designed to improve medication adherence within larger 
community mental health settings that treat a variety of mental and emotional conditions. 
Therefore, one of the preliminary purposes of this study was to design an exploratory program 
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designed to increase participants’ general knowledge about commonly prescribed medications 
within a community mental health setting. A second preliminary purpose of this study was to 
evaluate the effectiveness of such a program at increasing participants’ adherence to their 
medication regimens. The findings would thus help to determine if such a program is feasible, 
economical, and effective within similar community samples and to determine if such a 
procedure should be repeated in the future. The hurdles that were discovered following the 
implementation of the preliminary study design led to a third purpose of this study which was to 
understand ways to modify the preliminary program to best meet the needs of Psychology Clinic, 
the psychological service and training clinic for a small, private university in the Pacific 
Northwest.  
Preliminary Logic Model 
A logic model illustrating the proposed program design was created and is depicted in 
Figure 1 (Frechtling, 2007). The components consist of a Problem Statement, a Goal, a 
Rationale, Assumptions, Resources, Activities, Outputs, and Outcomes. The Problem Statement 
is that individuals within a community mental health setting are not taking their medications as 
prescribed and are thus not reaping the full benefits from their treatments. The Goal is to increase 
medication adherence rates in adults who receive medication services at Psychology Clinic 
through a targeted psychoeducational program. The Rationale behind this program is that 
research suggests that targeted psychoeducational programs can improve general knowledge 
within a mental health setting, and that this information may lead to better compliance with 
medication regimens. The Assumptions that underlie this model is that there are resources 
available within the Psychology Clinic community that can be cultivated to create an 
economically feasible psychoeducational program with little additional expenses. The Resources 
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available are student clinicians, a nurse practitioner, office staff personnel, two pharmacists, a 
designated office space, snacks, fliers, and assessments to measure effect of the program on 
patients’ medication adherence levels. The Activities necessary for this program are 
advertisements to enlist interested parties, monthly psychoeducational meetings performed by 
knowledgeable pharmacists, and extensive follow up to determine the effect of such a meeting 
on medication adherence rates using reliable and established measures. The expected Outputs are 
the number of classes an individual attends and their responses on the assessments designed to 
evaluate their medication practices. The expected Outcomes are that attendees will increase their 
knowledge about their medications which in turn will increase adherence to medication 
regimens. Additional but less targeted outcomes include overall symptom improvement within 
therapy.   
Figure 1. Logic model for the development of a psychoeducational program designed to educate 
patients about their medications.  
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Preliminary Study Design 
On the basis of the principles illustrated in the logic model, an exploratory pilot study 
was designed to test the theory that a psychoeducational program could effectively increase 
medication adherence rates in patients within a community mental health setting.   
Description of Participants 
 The preliminary study design was set up to utilize participants who were current clients at 
Psychology Clinic who were over the age of 18 and who were interested in receiving additional 
information about their psychotropic medications. The participants must be prescribed 
medications through the on-site nurse practitioner to control the type of information that would 
be presented within the informational meetings and to tailor the information to specific drug 
classes.  
Recruitment 
Ideally, a systematic recruitment procedure would be used to entice individuals to attend 
a psychoeducational meeting. At Psychology Clinic, clients who request to have medication 
referrals are required to meet with the on-site nurse practitioner for an initial evaluation to inform 
them about what to expect from the medication(s) they may be prescribed. After this initial 
meeting, the patient is typically requested to schedule one or two follow-up visits with the nurse 
practitioner to adjust doses if necessary and to monitor medication effectiveness. Therefore, the 
proposed study procedure would require the front desk staff to inquire at this initial appointment 
if the client wished to be involved in a study that would ask about their medication practices and 
would also provide them with an opportunity to attend an optional psychoeducational meeting at 
the clinic. Those who would agree to participate would be included in the study and would be 
given an informed consent document detailing their duties as a participant. Additionally, fliers 
would be posted throughout the waiting room to advertise the details of the informational 
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meetings (See Appendix 1). Clinicians would also be informed about the study via a didactic 
training seminar so that they could advertise the benefits of the psychoeducational program to 
their clients.  
Setting 
 Ideally, this study would be conducted at two connected community mental health clinics 
that are affiliated with the university. Both clinics provide brief and long term mental health 
services to children, adults, couples, and families within the greater Pacific Northwest for 
reasonable and often reduced fees. The pilot psychoeducational program was designed to be 
conducted in each clinic’s group space which would seat up to 20 adults.   
Preliminary Program Design 
 The psychoeducational program meetings were designed to occur twice per month, once 
at each clinic setting, and were intended to be repeated each month until enough preliminary data 
was collected to be analyzed. They were also designed to occur on a consistent day of the month 
during the evening at each setting so as to be compatible with clinician and client schedules. The 
program was designed to last approximately an hour and a half, depending upon the amount of 
questions and the number of attendees. The program curriculum was set to repeat each month so 
that individuals could receive comprehensive information by attending any meeting that was 
most convenient for their schedules. The curriculum of the meeting was designed by David 
Fuentes, PharmD., a licensed pharmacist within the university’s pharmacy training program. It 
was created to address basic diagnostic conditions that would be seen most frequently by 
clinicians at both clinic locations, and topic areas would include discussions about depression, 
anxiety disorders, bipolar disorder, and psychotic disorders. The curriculum would also include 
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additional time at the end of each meeting for a discussion about any remaining concerns that 
attendees might have.  
 The meetings were structured to involve discussions about relevant prescribed 
medications utilized by the nurse practitioner. Topics were planned to include general 
medication information, information about side-effects, information about who to turn to for 
help, and descriptions about what an overdose might look like. The program was designed to 
have an active learning format, and thus each meeting would have been presented somewhat 
differently depending upon the types of questions and personal experiences of the attendees. 
There was also an open discussion and personal reflections component to the meeting curriculum 
which was designed to engage the audience and to allow for maximum information retention.  
Medication Adherence Assessment Tool 
 An additional component of this proposed study was an evaluation of the effectiveness 
each meeting had at improving medication adherence rates in attendees. Therefore, a 
measurement was created to assess for adherence behaviors. Within the literature, one of the 
most commonly used measures of adherence rates in medical communities is the Morisky 
Medication Adherence Questionnaire (MAQ; Shalansky, Levy, & Ignaszewski, 2004). It contains 
several yes or no questions that assess past medication use, and it is easy to administer to a 
variety of patients. In a sample of patients with hypertension, the MAQ significantly and 
independently predicted non-adherence, and it had variable internal consistency between .32 to 
.86. The authors indicated that the MAQ might not be well-suited to populations with low 
adherence base rates, and thus it was not chosen for this study.   
An additional measure cited within the literature is the A14 Scale of medication 
adherence (Jank, Bertsche, Schellberg, Herzog, & Haefeli, 2009). It was generated to combat 
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some of the flaws with the MAQ. The A14 was designed to identify specific barriers to 
adherence that might help clinicians or prescribers in designing intervention strategies. The non-
adherence behaviors assessed by the A14 are divided into several categories; non-adherence due 
to forgetfulness, patient adaptations to regiments not suggested by the prescriber due to safety or 
efficacy reasons, non-adherence due to practical life concerns like finances, and non-adherence 
due to negative attitudes about the drugs and/or side effects. The items are rated by the 
participant along a 5-point Likert scale with anchors of never and very often. Scores can range 
from zero to 56, and a score above 50 would be classified as adherent. The developers 
administered the A14 in a sample of 150 cardiac patients with chronic medication regimens at 
the University Hospital Heidelberg in Germany, and the measure was found to have good 
internal consistency (Cronbach’s alpha was .86) and superior psychometric properties to the 
MAQ. Due to the fact that the A14 was also found to be a useful tool in both medical and mental 
health settings because it was able to identify barriers that could then be used as targeted 
medication adherence interventions, it was chosen as an adherence measure for this preliminary 
study design. Slight modifications were made to make it more relevant to the community mental 
health population and to reduce bias language. Additional questions were also added to the 
measure to differentiate between those who chose to attend an informational meeting from those 
who did not, and to specify which condition(s) an individual was seeking treatment for. The final 
measure was entitled the Medication Adherence Measure (MAM; See Appendix 2). 
Preliminary Procedure Part I:  Assessment of Medication Adherence 
 The preliminary procedure called for  participants to sign an informed consent form at the 
time of their initial medication evaluation appointment by the front desk staff who would inform 
them that there were optional monthly medication informational meetings at each clinic. The 
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participant would also be informed that attendance at an informational meeting was an optional 
component of the study. If there were any questions at this point, participants were directed to 
their therapists who had been briefed about the study design. Participants would then be handed 
the one-time demographic questionnaire (See Appendix 3) and a copy of the Medication 
Adherence Measure (MAM) by the front desk staff. The initial MAM would measure the 
participant’s standard medication adherence practices at baseline. In the preliminary procedure, 
two additional numerically linked duplicate MAM measures would be stored in the client’s file 
so that the participant’s adherence rates could be measured over time at each subsequent follow-
up meeting with the nurse practitioner. Each measure would be labeled with a linked ID number 
(different iterations would be labeled A, B, and C), and all identifying information would be kept 
confidential and separate from measurement results. All measures would be stored within the 
client’s file so that they could be easily found for each measurement interval and could be 
provided to the client in the waiting room by the front desk staff prior to his or her medication 
appointment.    
Preliminary Procedure Part II:  Assessment of General Knowledge   
 In a study by Alliger and Janak (1989), the authors emphasized the common disconnect 
between learning and resulting behavior change, and they suggested that an assessment of one’s 
reactions or knowledge after a given training program should be conducted in order to predict the 
potential for future behavior change. Therefore, a measure was designed to assess the general 
knowledge of the informational meeting attendees at the two clinics to determine what degree of 
information they retained from the program.  
  For this part of the preliminary procedure, a questionnaire entitled the General 
Knowledge and Opinions Measure (GKOM; See Appendix 4) was developed based on the 
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program curriculum designed by Dr. Fuentes. It was loosely based on a similar measure of 
retained knowledge developed by McKay and Corkum (2006) in their study of the effects of a 
psychoeducational program designed for children and families with ADHD. The GKOM was 
also designed to be stored in the client’s file and would be administered prior to a medication 
appointment. Similar to the MAM, each measure contained a participant ID number, and each 
installment was identified by letter. However, unlike the MAM, for this part of the procedure, the 
participant would only be asked to fill out the GKOM after attending an informational meeting.  
Preliminary Procedure Part III: Assessment of Treatment gains 
 LaFleur and Oderda (2004) suggested that researchers should investigate the effects of 
their interventions on clinical outcomes to determine if symptom improvement was obtained. 
Therefore, one of the preliminary components of this study was to investigate the effect that a 
psychoeducational program had on treatment outcome by way of improved compliance with 
medication regimens. A measure was created to assess a participant’s overall treatment gains 
within the therapy setting, and it was entitled the Measure of Treatment Gains (MTG; See 
Appendix 5). Unlike the previous assessments, the MTG was designed to be completed by the 
therapist after each meeting with the nurse practitioner. Duplicate copies for the therapist would 
also be stored within the client’s file with the other measures to allow for easy access by the 
clinician.  
Procedure Implementation and Impediments 
 This preliminary study design was put into place as described in the spring of 2011. 
Three informational meetings were conducted at each clinic location during that time. From its 
inception, there were no participants who agreed to be included in this study and no one chose to 
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attend the free informational meetings. Several suggestions were made regarding how to improve 
recruitment, and several modifications were made to the preliminary procedure.  
Collection of Data 
 After the procedure was implemented, the front desk staff began to report that data 
collection would be too time consuming for them to complete in addition to their regular duties. 
The procedure was therefore modified to allow for a separate research assistant to collect the 
data at all data points. This research assistant would monitor when participants had a medication 
appointment and would prepare the file with the appropriate measures. As this problem was 
corrected, a new problem became apparent.  
Clinician Involvement 
 Part of the procedure required clinicians to talk with their clients if participants came to 
them with questions about the study. Clinicians were also asked to help advertise the benefits of 
the informational meetings to their clients. However, despite a didactic training about the study 
design and reminder emails about discussing the psychoeducational meetings with clients, few 
clinicians reported doing so. This was in contrast to many clinician reports that a 
psychoeducational meeting would greatly benefit several of their clients.  
Participant Recruitment 
 There were several components of the original procedure that were designed to make 
attendance at an informational meeting feasible for clients. The informational meetings were 
offered at each of the locations where clients already received therapy services. They were 
completely free and were offered in the evening so as not to conflict with normal working hours. 
They were also repeated monthly so that individuals could choose which meeting worked best 
with their schedules. Additionally, there were fliers available within the waiting rooms to 
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advertise the meetings to clients. However, despite these efforts, there were no participants in the 
study and there were no attendees at any of the three meetings held throughout the study. 
Although this finding was likely the result of a culmination of the concerns discussed, it was 
baffling due to the fact that several clinicians had expressed their endorsement of such a program 
during a preliminary focus group conducted one year prior to this study. Those clinicians 
overwhelmingly approved of a program designed to educate clients about their medications as a 
way to improve their clients’ medication adherence rates. Therefore, in order to understand how 
to adjust the proposed program so as to obtain the desired outcome of medication adherence 
improvement, a more targeted focus group was conducted. This time, the goal would be to 
discover ways to improve the existing procedure to combat poor participant and clinician 
involvement.  
Focus Group Method 
Description of Participants 
 In an effort to determine what caused the preliminary study to fail, student clinicians 
were recruited at both clinics to answer questions about how to improve medication adherence in 
their clients via a psychoeducational program (See Appendix 6 for a list of the questions asked). 
There were seven clinicians total who agreed to be part of the focus group. The first four were 
from the west side clinic, and the last three were from the centrally located clinic. Clinicians 
varied in their level of experience from 2 to 5 years of training. There were two men who agreed 
to participate and five women.  
Setting 
 Clinicians were interviewed at both clinic locations of the Psychology Clinic within the 
group rooms.  
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Procedure 
 The focus groups were established as a way to elicit feedback about the failed 
preliminary study design procedure. The suggestions made would be incorporated into a new 
logic model for future study designs. Ideally, a new procedure would be generated to obtain the 
desired outcome of improved medication adherence amongst community mental health patients. 
Student clinicians were informed of the focus groups via a clinician listserv email that asked for 
feedback about the failed procedure. Volunteers were those who were available during the two 
hour window that was provided in the email. Each participant signed an informed consent form 
indicating that their answers would be kept anonymous but could also potentially be used to 
influence future implementations of the preliminary study design. During the focus groups, the 
questions were written on a white board within the room, and each individual was asked to 
provide their honest opinion on each topic. Their responses are summarized below.  
Participant One 
 This participant stated that she had a client that asked her repeatedly about his 
medications and how they might impact his life. She stated that she often felt stumped when he 
did this because she did not have enough training to answer his questions fully and she had 
limited knowledge about where to refer him to for information.  When asked about any general 
suggestions she had to improve patient knowledge about commonly prescribed medications, she 
stated that she would like to see better integration between Psychology Clinic and the pharmacy 
program also housed within the university. She stated that there are few interdisciplinary 
connections within the professional programs, and she would like to see this change so that she 
could easily make referrals to other in-house professional services. This would improve overall 
coordination of care, and it would allow patients easy access to much- needed services.  
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 When asked about how to specifically improve medication adherence rates, this 
participant stated that she would like to see the nurse practitioner become more available, 
especially for medication consultation. She stated that accessibility by phone would help clients 
get answers to common questions without having to wait up to a month for a one on one 
appointment. She also suggested that the clinic hire an additional nurse practitioner, if even as a 
trainee, to increase the number of available appointments.  
 When asked about the utility of this psychoeducational program, she stated that she saw 
the fliers within the clinic but did not remember to inform her clients about the program. She 
stated that if her supervisors had repeatedly endorsed the medication information meetings, she 
may have remembered more easily that they were available and appropriate for her clients.  
Participant Two 
 The second participant reported that she had several clients who were taking psychotropic 
medications that were prescribed through the nurse practitioner. She stated that one of her clients 
prematurely discontinued his medications due to negative side effects, but she was not 
adequately trained to discuss these concerns with her client. This participant suggested that 
clinicians receive proper training on medications and potential side effects so that this situation 
can be avoided in the future. She suggested that clinicians receive certification training through 
knowledgeable experts about psychopharmacology so that they can become certified, much like 
alcohol and drug counselor training. At the very least, this clinician strongly favored mandatory 
psychopharmacological training for all counselors prior to treating clients. This participant stated 
that she did not know why clients did not attend the informational meetings, but that after hours 
programs of any kind were routinely poorly attended by clients.  
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Participant Three 
 This participant had several clients who were receiving medication services through other 
sources. She stated that client attendance to educational or therapy-oriented programs has been a 
difficult problem to solve for many years and that she was not surprised that no one attended the 
informational meetings. However, she stated that at a different training site, she noticed one 
agency mitigating this problem by offering coupons that discounted therapy services in exchange 
for attendance to a group therapy service. Her suggestion was to utilize this option for the nurse 
practitioner services which can be quite expensive. If clients get a reduced fee to see the nurse in 
exchange for going to an educational meeting, she theorized that they may be more inclined to 
attend a psychoeducational program at this clinic.  
Participant Four 
 This participant stated that there is an unstated bias amongst student clinicians in that 
they often do not strongly value psychopharmacological treatments for mental health concerns. 
Despite the American Psychological Association’s standards of care (APA, 2002) that suggest 
well-rounded treatment plans that often include medication services, many novice clinicians are 
of the mindset that medications are unnecessary or perhaps even detrimental to a client’s well-
being. This participant stated that this cultural climate may have limited the amount of buy-in 
that clinicians had in supporting the preliminary psychoeducational program. This belief system 
may have prevented clinicians from discussing medications with their clients, and it may have 
also stopped them from discussing any medication-related programs as well. Therefore, this 
participant suggested that, should another program take place, supervisors would need to educate 
novice clinicians about this cultural belief system so that more buy-in could occur on behalf of 
the clinicians.  
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Participant Five 
 This participant suggested that the nurse practitioner become more available through 
consultation appointments so that clients could contact her with questions without having to wait 
for an available appointment. Additionally, this participant also suggested that a reduced fee be 
offered in exchange for attendance at a psychoeducational meeting. 
Participant Six 
 This participant had several clients who prematurely stopped their medication regimens 
without consulting the nurse practitioner because they could not get an appointment to see her. 
She stated that she was unaware that the medication information meetings existed and that she 
would have told her clients about them if she had know about them. When asked about how 
medication information might be best received by clients, she also suggested a consultation 
service so that clients could talk to someone quickly about their questions. Additionally, she 
suggested that visual aids be made available so that clinicians could have something they could 
hand to clients with common frequently asked questions and answers should they come to 
therapy with medication questions.  
Participant Seven 
 This participant also suggested that clinicians become educated about 
psychopharmacology instead of clients so that they could pass the information along to those 
who presented with questions. She stated that a certification program would likely be well 
received by most novice clinicians because it would give them a competitive edge in their 
training which would better prepare them for internship and other professional roles.  
 
 
Medication Adherence       
 
 
22
Focus Group Discussion  
 There were some common themes presented by participants in the focus groups. Most of 
the participants simply forgot about the psychoeducational meetings and therefore did not have 
discussions with their clients. Those who acknowledged this often cited increased supervisor 
buy-in as a possible solution to a lack of discussions with clients about the meetings. When 
asked about how medication information could best reach clients, most individuals believed that 
the nurse practitioner needed to be more available for consultation, perhaps through an 
answering service, to avoid a lengthy wait time between appointments. Additionally, several 
people suggested an incentive program such as reduced-fee coupons for those who attended a 
psychoeducational meeting about medications as a way to mitigate the trend of poor attendance 
at after-hours programs. This would help to mitigate the cultural barriers to 
psychopharmacological education that many novice clinicians reportedly share. One person 
suggested that the in-house pharmacy school be involved in referral services as well to ease the 
burden on the nurse practitioner. Also, several participants favored a counselor education 
program rather than a client-focused educational program so that clinicians could directly 
educate their clients whenever questions occurred.  
 If economic resources were available, several of these suggestions would be put into 
practice to determine if they could succeed at improving medication adherence rates. However, 
the current operating budget of Psychology Clinic does not allow for additional nurse 
practitioner services or outside consultation programs, so the consultation services with the 
pharmacy training program and the nurse practitioner answering service were not viable options. 
Additionally, it is unclear if there are economic resources available to offer reduced-fee 
incentives in exchange for attendance at an educational meeting as Psychology Clinic already 
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offers sliding-scale fees to help mitigate the expense of therapy and medication services for low-
income clients. Therefore, the most economically viable options given the resources available at 
this time are to offer a psychoeducational program for clinicians and to increase supervisor 
involvement to improve clinician buy-in.  
Revised Logic Model 
 The original logic model that was used to establish the failed preliminary program design 
was modified to incorporate the suggestions that were generated in the focus groups. The 
problem section of the new logic model will remain the same because poor medication adherence 
is still a well-documented problem within the mental health community. The goal, however, will 
now be to provide psychopharmacological training to clinicians so that they may then educate 
their clients when questions arise. The resources are similar to the previous model in that 
knowledgeable experts are on hand to train clinicians through involvement of the pharmacy 
program. Activities would likely change to involve developing a psychoeducational certification 
program for clinicians and a potential evaluation of medication adherence rates over time to 
assess for improvement. Outputs would change to include clinician attendance at an educational 
training program, and they would also include the results of any new outcome measures of 
adherence rates that were deemed appropriate. The Outcomes would likely become improved 
clinician knowledge about commonly prescribed medication, improved adherence to medication 
regimens on whatever relevant assessment tool was selected, and symptomatic improvement in 
therapy.  
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Figure 2. Revised logic model for the development of a psychoeducational program designed to 
educate clinicians about commonly prescribed medications.  
 
Focus Group Conclusion 
 The suggestions generated in the focus group led to the development of a new logical 
model that included a clinician educational training program rather than a client-focused 
educational program. Although this new program design shows promise, there are a few 
concerns that need to be addressed. One is that the culture of Psychology Clinic may be that 
medication services are not valued as much as therapy. This value will need to be addressed by 
involving the clinical supervisors who are unlikely to share this novice clinician bias. Anyone 
who attempts to develop a new program based on the logic model presented should be sure to 
generate full faculty support prior to implementation. Additionally, a certification training 
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program in psychopharmacology is something that the institution would have to support and 
approve. This may require some programmatic adjustments which may take time. A true 
certification program may not be feasible, but a mandatory training program for all novice 
clinicians may be possible with the proper resources. Additionally, there is limited evidence to 
suggest that clinician training will lead directly to improved education among clients. This link 
will be improved if the cultural values of the institution change to support a discussion about 
medication treatments. However, there are limited ways to assure that clinicians will adequately 
address the concerns of their clients following such a training program. The assessments needed 
to assess for medication adherence and treatment gains given this new model will need to be 
created or modified from existing options in whatever new program is developed. The measures 
created for the failed program design in this study may be modified to fit a future program 
design, but they may prove to be inappropriate given the change in focus suggested.   
 Overall, the feasibility of the new program suggested from the revised focus group is 
manageable, and only slight modifications to the university’s training practices and Psychology 
Clinic’s general practices are necessary to implement it. It is still relatively economically 
feasible, and the pharmacist involved in the original study is still willing to participate in any 
psychoeducational training program that is requested. The same resources are available, and the 
problem still exists. The next person who attempts to develop a program designed to improve 
medication adherence rates in this setting should receive better results if they follow the revised 
focus group recommendations, and hopefully this new project will make a lasting impact on 
Psychology Clinic for years to come.  
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General Discussion and Conclusions 
 As the literature suggests, medication adherence is a common problem within health 
settings, but especially mental health settings. Often, common medical practices leave little room 
for clients to receive all the information they may need when they are prescribed psychotropic 
medications for the treatment of psychological conditions. In many instances, complications or 
questions may arise, and clients who are not properly educated about what to expect from their 
medications may discontinue using them or may take them in a way that is not compliant with 
their prescriber’s instructions. This poor adherence to medicinal regiments can lead to fewer 
symptom improvements and poorer treatment outcomes. The resulting cost to society is huge 
(LaFleur & Oderda, 2004) in terms of unnecessary treatment remedies and increased recidivism 
rates. The consensus within the literature is that psychoeducational programs are effective and 
low cost ways of filling in the informational gaps clients sometimes experience within the 
medical community. The assumption is that information about how to take a prescribed 
medication properly and information about potential side effects may help a client adhere more 
fully to their medication regiments as they would hopefully be more informed about what to 
expect.  
 In many well-designed studies, psychoeducational programs brought about increased 
knowledge and improved adherence behaviors. Therefore, a psychoeducational training program 
was chosen as the best medium to inform clients at Psychology Clinic about their medications. 
Unfortunately, this program failed to yield any participants, and thus it was determined to be an 
ineffective strategy in this setting. Several barriers to attendance were identified and corrected, 
but ultimately a new strategy was needed. Focus group results yielded interesting theories on 
both why the designed program failed and how information could still be used to bring about 
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improved adherence in clients. The solution that was most agreed upon was a psychoeducational 
training model targeted at student clinicians rather than clients. This solution is practical and 
economical, but it has some flaws. First and foremost, the suggested certification model will 
require institutional approval, which may not be possible. Additionally, it will require clinician 
involvement in a culture where medication treatment modalities are less supported than 
therapeutic ones. And, perhaps most glaringly, there are few ways to ensure that clinician 
knowledge will directly translate to improved medication adherence in clients, as this is a step 
removed from the educational chain. It is problematic enough to attempt to generate behavior 
change in an individual through education, and it may prove to be even harder when the target 
individual is not receiving this information first hand. There are also some flaws with regard to 
outcome assessments in that it may be difficult to measure the desired outcome of such a model, 
especially given the assessment tools that are currently available.  
 Despite these concerns, a new clinician training program may not be as ill-fated as the 
program design outlined here. If Psychology Clinic decides to take on a clinician 
psychopharmacological training program aimed at improving client medication adherence, there 
are several steps that would need to occur. First, a psychoeducational training program would 
need to be designed that was applicable to novice clinicians. This program would need to 
incorporate basic psychopharmacological information about the most commonly prescribed 
medications in the clinic, and knowledgeable experts would need to be incorporated in the 
teaching process. As mentioned, there are members of the pharmacy school that would be willing 
to take on this role, but this too would require program approval. In addition to the program 
design component, the clinic would also need to address when and how the student clinicians 
would receive the information. It is likely that a psychopharmacological training program could 
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be implemented in installments via a workshop, but the feasibility of this modality would need 
institutional approval as well. Also, the supervisors would need to be included in this training so 
that they could in turn encourage the clinicians to pass the acquired information along to their 
clients. Hopefully, this would reduce the bias against psychopharmacological treatments that is 
reportedly part of the culture of the clinic. Finally, assessment tools would need to be generated 
or modified from existing versions to assess whether such a program yielded improved 
medication adherence. This assessment piece may not be feasible, but it should be attempted if 
possible. Several of the measures utilized within the failed program design could potentially be 
adapted to meet this need.  
 Should these changes be implemented, the revised focus group recommendations and the 
clinician education program described may be useful ways to bring about improved adherence 
rates within Psychology Clinic clients. However, it is up to the institution to determine if this is a 
problem that they currently wish to address. There are several components that need approval, 
and any single step may be vetoed, thereby obviating the continuation of the program. 
Additionally, those in charge may decide that adherence rates are not a primary concern at this 
time. In that case, it is possible to adapt this model to another setting if desired. The most 
important thing to consider is that the program design needs to be malleable given the existing 
situation at implementation. Few programs work exactly as designed, and changes may be 
needed to adapt the clinician training model in a feasible and realistic way. Despite the hurdles 
listed, however, psychoeducation is still the most feasible and recommended way to address the 
growing problem of medication adherence. Hopefully this new model will move community 
mental health clinics one step closer to making poor adherence a thing of the past.  
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Appendix 1 
Sample Flier 
 
Understand Your Medications! 
A Free Medication Education Class for the Public 
Come and meet with knowledgeable pharmacists to learn about commonly prescribed 
medications for psychological conditions.    
We can tell you anything you would like to know about your medicine including 
information about side effects and about how different drugs interact.   
Location:  Psychology Clinic 
Time:  March 15th, 2011 from 6 – 8pm in the group room 
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Appendix 2 
Medication Adherence Measure 
Have you attended an informational meeting regarding the medications that are commonly 
prescribed at Psychology Clinic? Yes________ No_________ 
 
Please circle the condition(s) for which you are seeking treatment at Psychology Clinic (Circle 
all that apply). If Other, please specify.  
Depression   Anxiety Bipolar Disorder Psychotic Disorder      Other___________ 
 
Regardless of your attendance at an informational meeting, please answer the following 
questions about your medication practices based on the following scale: 
       0----------------------1----------------------2---------------------3-------------------4 
Very Often                    Occasionally                                     Never/NA  
   
_____1.  When I get side effects from a drug, I stop taking it for good  
_____2.  When I get side effects from a drug, I stop taking it for a while (days or weeks)  
_____3.  When my symptoms get worse, I increase the dose of the respective drug myself 
_____4.  When a drug has no effect, I stop taking it for good  
_____5.  If necessary, I take an extra-dose or miss out a dose (e.g. because of traveling) 
_____6.  When my symptoms get better, I stop taking the respective drug for good  
_____7.  When my symptoms get better, I stop taking the respective drug for a while (days 
 or weeks)  
_____8.  When the costs or co-payment of my drug is too high, I stop taking it for good 
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_____9.  I take my medication less often or stop taking it for a while to make the  package/bottle 
last longer 
_____10.  When I do not manage to get my prescription refilled on time, I stop taking my 
 drug for a while 
_____11.  I do not take my drug at all, because in my opinion it is not good to treat my
 symptoms with drugs 
_____12.  Now and then I stop taking my drug for a while since I dislike taking drugs all  the 
time 
_____13.  I forget to take my drug  
_____14.  I am unable to take my drug due to my medical condition (e.g. because I am not 
 able to open the package or swallow the tablet) 
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Appendix 3  
Demographic Information 
Age:    __ 
 
   Gender:      ____  Male 
          ____  Female 
        ____  Other 
 
Race or Ethnicity (please identify): ________________________________ 
 
Primary language (please identify):  _______________________________ 
 
    Marital Status:   ____   Single/never married 
                                                            ____   Divorced/legally separated  
                                                                        ____   Widowed 
                     ____   Married or in a long-term relationship 
 
                Highest level of education completed: ____   Grade school  
              ____   High school diploma/GED 
             ____   Some college 
           ____   College or beyond 
 
 
Medication Adherence       
 
 
36
Appendix 4 
General Knowledge and Opinions Measure 
Please answer the following questions only after you attended a medication informational 
meeting (if applicable) at Psychology Clinic.  All information will be kept confidential and 
anonymous. Thank you for your participation.   
 
1.  How useful did you find this meeting?  Please circle one.  
1    2            3  4     
   Not at All Useful        Somewhat Useful   Moderately Useful        Very Useful 
 
2.  What condition(s) were you seeking information for?  Please circle all that apply. If Other, 
please specify.  
Depression      Anxiety     Bipolar Disorder Psychotic Disorder            
Other_______________ 
 
3.  What medication(s) are you currently taking for a mental health condition as prescribed by 
Psychology Clinic? 
 
4. Are you currently taking any other prescription medications for other medical or mental health 
conditions that are not prescribed by Psychology Clinic? If so, please list all that you can 
remember, or if this does not apply, please leave this question blank.  
 
 
5.  After attending this meeting, why do you feel that it is important for you to take your 
medications as prescribed? 
 
 
 
6.  What are some of the side effects that you learned about for your prescribed medication or 
medications? 
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7.  After attending this meeting, at what point might you seek additional help from your 
prescriber? 
 
 
8.  After attending this meeting, at what point do you feel that would you be in danger of 
overdosing on your medication(s)? 
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Appendix 5 
Measure of Treatment Gains 
Note to clinicians:  This measure is part of an investigation on treatment improvements in 
association with a psychoeducational program on medications provided at Psychology Clinic.  
As part of this study, you will be asked to fill out this form after you have referred a client to the 
Nurse Practitioner for an initial evaluation and once per month for two months following this 
first appointment in order to assess whether treatment gains occurred during this time. It is 
expected that follow up dates will be as close to the date of the initial appointment as possible 
(i.e. if the client had his/her first appointment on the 15th of the month, this should be the time of 
the month that you should fill out the form for the other two data points). This form will be the 
same for all three measurement points, but each installment will be denoted with either an A, B, 
or C to denote when it occurred. Also, some questions may not be applicable at all measurement 
points, and these exceptions are clearly stated. It is expected that additional follow-up 
appointments with the Nurse Practitioner will occur during this two month measurement time 
frame, and thus this form will assess whether treatment gains accompany medication services. 
Thank you for your participation.  
 
1.  What diagnosis or diagnoses (Axis I only) did this client have at the time of the referral to the 
Nurse Practitioner? 
 
 
2.  What was this client’s standard outcome score (OQ score) at the time that a referral for 
medication was made? 
 
 
3.  What is this client’s current OQ score? (Answer only if this is the second or third 
measurement point and leave blank if this is the first time you have filled out this form).  
 
 
4.  How much improvement have you seen in this client’s presenting problem since his or her 
meeting with the Nurse Practitioner? Please circle one. (Please answer this question only if this 
is the second or third time you are filling out this form for your client). 
 
1   2   3   4   5 
None           Some        Moderate                A Significant       Symptom 
                Amount                   Remission 
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Appendix 6 
Focus Group Questions Principal Investigator. 
1. How many of your clients are getting medications though the nurse practitioner?  
 
2. Are you talking to your clients about their medications? What kinds of things do you 
talk about? What kinds of questions do your clients have? 
 
3. Have any of your clients brought up concerns about their medications to you?  
 
4. Are you aware that non-adherence to medication regiments is a problem within the 
mental health field? 
 
5. Over the last few months, a procedure was implemented which was designed to 
inform clients about their medications as a way to help them take their medications 
as prescribed. However, client participation was minimal. What suggestions do you 
have to make an informational meeting more accessible to clients? 
 
6. What other ways might clients receive information about their medications? 
 
7. What economically feasible suggestions do you have to improve medication 
adherence rates amongst clients who seek mental health services? 
 
8. Do you have any specific suggestions regarding the procedure that was 
implemented that might make it more feasible in the future? 
 
 
